Dirac Biosciences

Active

Private limited companyfounded 20233 yrs activeLouizalaan 480, 1050 Elsene, BelgiumKBO/BCE: BE 0797.089.778

Summary

The computed 12-month bankruptcy probability of Dirac Biosciences is 5.8% (elevated). The 2024 annual accounts show negative equity (-€4,107) and a net result of -€919. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch Report Compare

Dirac BiosciencesActive

Risk analysis Report Compare

Activity

Activity not known1 site

Size

€0total assets 2024

Equity: -€4,107
Loss: -€919

Financial health

Bankruptcy chance 12 m: 5.8%

Too few figures to score

Structure

Parent: eureKASYNBIO · 100%

Accounts 64 d overdue0 of 2 deeds read

Signals- Founded in 2023- No main activity registered- 1 financial year not filed after the legal deadline; latest accounts 57 days late; 2 of the last 3 late- Negative equityFiled after the deadlineShow the evidence

Checked score

No current score

Insufficient figures

A score requires measurable solvency, liquidity and profitability.

Bankruptcy probability: Elevated

Bankruptcy probability, 12 months

5.8% Elevated

0%0.5%1.5%4%10%≥ 25%

About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 11-2024: 5.6% 12-2024: 5.6%● 0.0% vs 11-2024 01-2025: 5.5%▼ -1.7% vs 12-2024lowest value 02-2025: 6.4%▲ +16.3% vs 01-2025 03-2025: 6.4%▼ -0.7% vs 02-2025 04-2025: 6.4%▼ -0.4% vs 03-2025 05-2025: 6.4%● 0.0% vs 04-2025 06-2025: 6.4%● 0.0% vs 05-2025 07-2025: 6.4%▲ +1.0% vs 06-2025 08-2025: 7.5%▲ +16.1% vs 07-2025 09-2025: 7.9%▲ +5.4% vs 08-2025highest value 10-2025: 5.7%▼ -27.3% vs 09-2025 11-2025: 5.7%▼ -1.2% vs 10-2025 12-2025: 5.7%● 0.0% vs 11-2025 01-2026: 5.7%● 0.0% vs 12-2025 02-2026: 5.7%● 0.0% vs 01-2026 03-2026: 5.7%● 0.0% vs 02-2026 04-2026: 5.7%● 0.0% vs 03-2026 05-2026: 5.7%● 0.0% vs 04-2026 06-2026: 5.7%● 0.0% vs 05-2026 07-2026: 5.7%● 0.0% vs 06-2026 08-2026: 5.8%▲ +2.0% vs 07-2026 09-2026: 5.8%● 0.0% vs 08-2026 10-2026: 5.8%● 0.0% vs 09-2026

Founded in 2023 raises the probability for this profile
No main activity registered raises the probability
1 financial year not filed after the legal deadline; latest accounts 57 days late; 2 of the last 3 late raises the probability

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.

+raises risk○neutral

Founded in 2023

In the bankruptcy model this factor raises the probability for this profile.

KBO

No main activity registered

In the bankruptcy model this factor raises the probability.

KBO

1 financial year not filed after the legal deadline; latest accounts 57 days late; 2 of the last 3 late

In the bankruptcy model this factor raises the probability.

NBB · filings

Negative equity

The 2024 annual accounts show negative equity and a net loss.

NBB · annual accounts 2024

Equity per financial year

2324

2023 to 2024 · latest year -€4,107

Filed after the deadline

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 26-09-2025, 57 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 2 filings

Deviation from the deadline

2025

not confirmed

2024

57 d late

2023

64 d late

← before the deadline after the deadline →

tick = median of all Belgian filings

This company filed its last 2 accounts on average 61 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage